Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity

Journal of Parkinson s Disease(2022)10.3233/jpd-213128Source: DataRank Database

Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity is a research paper published in Journal of Parkinson s Disease (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: bronzeTopics (54)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Vinita G. Chittoor-Vinod ORCID,Jillian H. Kluss ORCID,Kaela Kelly ORCID,Nicole Bryant ORCID,An Phu Tran Nguyen

Live enrichment

PubMed:35599495

National Institutes of Health

Grant: 1P50NS062684-01A1

Pacific Northwest Udall Center

National Institutes of Health

Grant: 5P41GM103311-36

Resource for Biocomputing Visualization and Informatics

National Institutes of Health

Grant: 1UF1AG057707-01

Neuropathologic substrates for motor and cognitive impairment in three existing cohort studies of Alzheimer's disease and related dementias

National Institutes of Health

Grant: 5R01NS064934-11

Mechanisms of LRRK2 Mediated Neurotoxicity

National Institutes of Health

Grant: 5P50NS108675-02

Innate and Adaptive Immunity in Parkinson Disease

NINDS NIH HHS

Grant: P50 NS108675

NINDS NIH HHS

Grant: R01 NS064934

bronzeLicense: CC BY NC

publisherhttps://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd213128?id=journal-of-parkinsons-disease%2Fjpd213128

publisherhttps://content.iospress.com/download?id=10.3233/JPD-213128

repositoryhttps://doaj.org/article/817839d7784c4612be355c1d5e6f3072

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9398093

https://doi.org/10.3233/jpd-213128

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesAnimalsFibroblastsHEK293 CellsHumansLeucineLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MiceMutationParkinson DiseasePhosphorylationRatsReproducibility of Resultsrab GTP-Binding Proteins

MeSH Terms

AnimalsFibroblastsHEK293 CellsHumansLeucineLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MiceMutationParkinson DiseasePhosphorylationRatsReproducibility of Resultsrab GTP-Binding Proteins

Keywords

kinaseBiophysics610Leucine-Rich Repeat Serine-Threonine Protein Kinase-2BiochemistryRAB proteinMiceOther BiochemistryLeucineMichael J. Fox Foundation – Replication PaperAnimalsHumansPhosphorylationproximity ligation assayLife SciencesReproducibility of ResultsLRRK2Parkinson DiseaseFibroblastsRatsHEK293 Cellsrab GTP-Binding ProteinsMutationand Structural BiologyBiotechnology

Sustainable Development Goals

SDG 3: 3. Good health